Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
latest_posts
- 1
NASA satellite gazes into Medusa Pool | Space photo of the day for Dec. 24, 2025 - 2Greece eyes migrant repatriation centres outside the EU
- 3Insight: Pills, TikTok, weight-loss apps and the consumer-driven future of GLP-1s
- 4From record warming to rusting rivers, 2025 Arctic Report Card shows a region transforming faster than expected
- 5Conquering Language Boundaries: Individual Accounts of Multilingualism
- The Conclusive Manual for Spending plan Travel: Opening Undertakings on a Tight budget
- An 'explosion' of solo-agers are struggling with rising costs and little support: 'I'm flying without a net'
- Vice President Dick Cheney’s life followed the arc of the biggest breakthroughs in cardiovascular medicine
- NASA chief Jared Isaacman says Texas may get a moonship, not space shuttle Discovery
- Turkiye’s Erdogan calls Israel’s Somaliland recognition ‘unacceptable’
- Flu season is underway. What are common symptoms to watch for?
- How to watch 'A Charlie Brown Christmas' for less with this Apple TV Black Friday deal
- In vogue Sleepwear Patterns for 2024
- Ukraine Now Using Drone Boats To Attack Russian Riverine Targets
